J.SamuelsB
Schedule a complimentary skin consultation with our Licensed Aesthetician at GreeneMD to see how this innovative treatment can fit into your skincare routine.

Cardiovascular Studies Cardiac Protection Research has demonstrated BPC-157's potential cardioprotective effects [21]: Protection against arrhythmias induced by various drugs Improved cardiac function after ischemic injury Enhanced coronary blood flow Reduced infarct size in heart attack models Blood Vessel Effects Studies on blood vessel healing show BPC-157 promotes: Arterial healing after injury Venous healing and reduced thrombosis Collateral vessel development Endothelial function improvement Benefits by Category with Evidence Ratings Gut Healing Strong Evidence Evidence Rating: Strong (Multiple animal studies, consistent results) The gastrointestinal applications of BPC-157 have the most robust research support: Ulcer healing (gastric and duodenal) NSAID-induced damage protection and reversal Inflammatory bowel conditions Intestinal permeability ("leaky gut") Esophageal damage healing Liver protection The consistency of results across multiple studies and various injury models provides strong preclinical evidence

The Therapeutic Goods Administration (TGA) granted approval in December 2024 for semaglutide 2.4 mg, sold under the brand name Wegovy, to be used as a complementary therapy for adults with both cardiovascular disease and high body mass index, to reduce the related risk of heart attack, stroke or death
Think of it as refilling a completely empty tankit takes a concentrated effort at first to get things running smoothly again
Witschi A, Reddy S, Stofer B, Lauterburg BH